CD8A and neoplasm: Our results demonstrate that SH003 and DTX effectively inhibit tumor growth by inducing apoptosis in an anti-PD1-resistant lung cancer LLC1 model, while enhancing the infiltration of cytotoxic CD8+ T cells and NK cells into the tumor microenvironment (TME), thereby boosting anti-tumor immunity.